We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
-3.14%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$52.8B
AUM Growth
-$1.34B
Cap. Flow
+$1.39B
Cap. Flow %
2.62%
Top 10 Hldgs %
12%
Holding
4,607
New
780
Increased
956
Reduced
789
Closed
1,336

Top Buys

Rank Stock Value
1
MRK icon
Merck
MRK
+$532M
2
WFC icon
Wells Fargo
WFC
+$480M
3
V icon
Visa
V
+$435M
4
VZ icon
Verizon
VZ
+$320M
5
AVGO icon
Broadcom
AVGO
+$273M

Sector Composition

Rank Sector Weight
1 Financials 18.66%
2 Technology 16.35%
3 Healthcare 16.13%
4 Consumer Discretionary 11.2%
5 Industrials 7.53%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
KNDI
1451
Kandi Technologies Group
KNDI
$63.5M
$4.38M 0.01%
1,369,587
-94,920
-6% -$302K
DLCAW
1452
CALL
DELISTED
Deep Lake Capital Acquisition Corp. Warrant
DLCAW
$4.38M 0.01%
445,024
SWCH
1453
DELISTED
Switch, Inc. Class A Common Stock
SWCH
$4.37M 0.01%
141,806
+124,560
+722% +$3.32M
TRHC
1454
DELISTED
Tabula Rasa HealthCare, Inc. Common Stock
TRHC
$4.36M 0.01%
+758,115
New +$6.8M
HRT
1455
DELISTED
HireRight Holdings Corporation
HRT
$4.36M 0.01%
+254,750
New +$3.43M
AEACW
1456
CALL
DELISTED
Authentic Equity Acquisition Corp. Warrant
AEACW
$4.35M 0.01%
444,211
SHACW
1457
CALL
DELISTED
SCP & CO Healthcare Acquisition Company Warrant
SHACW
$4.34M 0.01%
443,917
PFTA
1458
DELISTED
Perception Capital Corp. III Class A Ordinary Share
PFTA
$4.32M 0.01%
440,294
DEVS
1459
DELISTED
DevvStream Corp
DEVS
$4.31M 0.01%
43,442
+3,432
+9% +$339K
CVET
1460
DELISTED
Covetrus, Inc. Common Stock
CVET
$4.31M 0.01%
256,965
+137,607
+115% +$2.41M
XLC icon
1461
State Street Communication Services Select Sector SPDR ETF
XLC
$22.6B
$4.31M 0.01%
62,707
-64,755
-51% -$4.56M
EG icon
1462
Everest Group
EG
$15.8B
$4.31M 0.01%
+14,299
New +$4.11M
CBD
1463
DELISTED
Companhia Brasileira de Distribuicao
CBD
$4.31M 0.01%
854,884
+418,119
+96% +$1.77M
EQHA.WS
1464
CALL
DELISTED
EQ Health Acquisition Corp. Redeemable Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50 per share
EQHA.WS
$4.3M 0.01%
438,502
PBH icon
1465
Prestige Consumer Healthcare
PBH
$2.45B
$4.3M 0.01%
+81,151
New +$4.69M
GTACW
1466
CALL
DELISTED
Global Technology Acquisition Corp. I Warrant
GTACW
$4.29M 0.01%
429,791
RCFA
1467
DELISTED
Perception Capital Corp. IV
RCFA
$4.27M 0.01%
+429,955
New +$4.25M
IMXI icon
1468
International Money Express
IMXI
$398M
$4.26M 0.01%
+206,941
New +$3.56M
EBAC
1469
DELISTED
European Biotech Acquisition Corp. Class A Ordinary Shares
EBAC
$4.26M 0.01%
437,091
+23,378
+6% +$227K
PHYT.WS
1470
CALL
DELISTED
Pyrophyte Acquisition Corp. Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share
PHYT.WS
$4.25M 0.01%
425,200
JUN.WS
1471
CALL
DELISTED
Juniper II Corp. Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50
JUN.WS
$4.24M 0.01%
426,300
+276,301
+184% +$150K
PRSTW
1472
CALL
DELISTED
Presto Technologies, Inc. Warrant
PRSTW
$4.23M 0.01%
418,879
+68,879
+20% +$21.8K
ACII.WS
1473
CALL
DELISTED
Atlas Crest Investment Corp. II Redeemable Warrants, each whole warrant exercisable for one Class A common stock at an exercise price of $11.50
ACII.WS
$4.23M 0.01%
431,000
CLRMW
1474
CALL
DELISTED
Clarim Acquisition Corp. Warrant
CLRMW
$4.22M 0.01%
431,013
PNST
1475
DELISTED
Pinstripes Holdings, Inc.
PNST
$4.22M 0.01%
+424,998
New +$4.22M

Similar funds

Marshall Wace's Q1 2022 Portfolio in Review

As of Q1 2022, Marshall Wace held 4,607 positions worth $52.8B, down 2.5% from $54.2B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Marshall Wace's Q1 2022 filing shows 780 new, 956 increased, 789 reduced and 1,336 closed positions. Its largest new stake was Agilent Technologies: 1,082,487 shares worth $143M. The largest sale was Microsoft, an estimated $547M.

By sector, the portfolio is most concentrated in Financials at 19% of assets, up from 16% a quarter earlier, followed by Technology and Healthcare.

  • Marshall Wace's largest Q1 2022 buy was Agilent Technologies: 1,082,487 shares worth $143M.
  • Marshall Wace added most to Merck in Q1 2022, an estimated $532M increase.
  • Marshall Wace's biggest Q1 2022 reduction was Microsoft, cutting an estimated $547M.
  • Marshall Wace fully exited Elevance Health in Q1 2022, selling an estimated $226M.
  • Marshall Wace's ten largest holdings make up 12% of its $52.8B portfolio in Q1 2022.
  • Marshall Wace opened 780 new positions and closed 1,336 in Q1 2022.
  • Marshall Wace's portfolio value fell 2.5% quarter-over-quarter to $52.8B.

Based on Marshall Wace's 13F filing for Q1 2022, filed 16 May 2022.